ARTICLE | Company News
ADC Therapeutics, Genmab deal
April 13, 2015 7:00 AM UTC
Genmab did not exercise its co-development right for HuMax-TAC-ADC under a June 2013 deal to develop an antibody-drug conjugate (ADC) product to treat cancer. The option would have allowed Genmab to m...